Psoriasis

NICE Clinical guideline [CG153] Psoriasis: assessment and management. Last updated Sep 2017. NICE CKS Psoriasis. Last revised Dec 2024.

Gudielines

Approach:
  • 1st line: topical therapy in primary care
  • 2nd line: phototherapy in secondary care
  • 3rd line: systemic therapy in secondary care
   

Refer to dermatology if:
  • There is uncertainty about the diagnosis.
  • Extensive psoriasis (>10% of body surface area
  • Moderately severe or above psoriasis, as measured by the Physician's Global Assessment.
  • Psoriasis is resistant to topical therapy in primary care
  • There is a significant impact on the person's physical, psychological, or social wellbeing.

If psoriatic arthritis is suspected → urgent referral to rheumatology.

Regular topical emollients should be offered to ALL patients in addition to the following topical therapy.

 
Step Topical Therapy Description
1st line Potent corticosteroid + vitamin D once daily for 4 weeks

1 in the morning and 1 in the evening.
If not effective after 4 week course of steroid → attempt another 4 week course
  • After 4 weeks of steroid therapy, a 4 week break in between is needed
  • During the 4 week break, vitamin D can still be used

If poor response after 8 week → step up to 2nd line
2nd line Vitamin D twice daily

(Stop the corticosteroid)
If poor response after 8-12 weeks → step up to 3rd line
3rd line Stop the vitamin D and offer:
  • Potent corticosteroid twice daily for 4 weeks, OR
  • Coal tar preparation twice daily
 
4th line Consider combined potent corticosteroid and vitamin D once daily for 4 weeks   
5th line Consider short-contact dithranol Also:
  • Consider alternative diagnosis
  • Refer to dermatology
 

Note that topical vitamin D preparations should be avoided in:

  • Use on face
  • Pregnancy
  • Breastfeeding
 

1st line: narrowband UVB light therapy

Other options:
  • Broad-band UVB light therapy
  • Psoralen plus UVA (PUVA) phototherapy

Frequency and doses:
  • 2-3 times a week
  • Dose is based on the person's 'minimal erythema dose' and sun-reactive skin type

First offer conventional systemic therapy 
  • 1st line: methotrexate
 
  • 2nd line: ciclosporin, should be offered instead of methotrexate as first line if any of the following:
    • Rapid / short-term disease control needed (e.g. psoriasis flare)
    • Patient is considering conception
    • Palmoplantar pustulosis
 
  • 3rd line: acitretin 
 

If conventional systemic therapy failed → consider targeted immunomodulatory therapy (initiated and supervised only by consultant dermatologists)

  • TNF-alpha inhibitors (e.g. adalimumab, etanercept, infliximab)
  • IL-12/23 inhibitor (ustekinumab)
  • IL-17 inhibitor (brodalumab)
  • IL-23 inhibitor (e.g. guselkumab)

1st line: topical potent corticosteroid once daily for 4 eeks

If no improvement after 4 weeks:
  • Try different formulation of topical potent corticosteroid, and/or
  • Apply topical agents to remove adherent scale before application of topical steroid

1st line: topical mild / moderate potent corticosteroid once / twice daily for 2 weeks

References

Author: Adams Lau
Reviewer:
Last edited: 05/05/25